Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 1 of the 24 sources its claims cite were checked for support.
Abstract
Epigenetic modifiers have fundamental roles in defining unique cellular identity through the establishment and maintenance of lineage-specific chromatin and methylation status. Several DNA modifications such as 5-hydroxymethylcytosine (5hmC) are catalysed by the ten eleven translocation (Tet) methylcytosine dioxygenase family members, and the roles of Tet proteins in regulating chromatin architecture and gene transcription independently of DNA methylation have been gradually uncovered. However, the regulation of immunity and inflammation by Tet proteins independent of their role in modulating DNA methylation remains largely unknown. Here we show that Tet2 selectively mediates active repression of interleukin-6 (IL-6) transcription during inflammation resolution in innate myeloid cells, including dendritic cells and macrophages. Loss of Tet2 resulted in the upregulation of several inflammatory mediators, including IL-6, at late phase during the response to lipopolysaccharide challenge. Tet2-deficient mice were more susceptible to endotoxin shock and dextran-sulfate-sodium-induced colitis, displaying a more severe inflammatory phenotype and increased IL-6 production compared to wild-type mice. IκBζ, an IL-6-specific transcription factor, mediated specific targeting of Tet2 to the Il6 promoter, further indicating opposite regulatory roles of IκBζ at initial and resolution phases of inflammation. For the repression mechanism, independent of DNA methylation and hydroxymethylation, Tet2 recruited Hdac2 and repressed transcription of Il6 via histone deacetylation. We provide mechanistic evidence for the gene-specific transcription repression activity of Tet2 via histone deacetylation and for the prevention of constant transcription activation at the chromatin level for resolving inflammation.
Overview
CoChat Summary
TL;DR
Tet2 actively represses Il6 transcription during the late phase of LPS-driven inflammation in myeloid cells by recruiting Hdac2 to the Il6 promoter, independent of DNA methylation. Tet2 loss prolongs IL-6 production and worsens endotoxin shock and DSS-induced colitis in mice.
Key findings
- In Tet2-deficient or Tet2-silenced dendritic cells and macrophages, the early LPS-induced rise in Il6 mRNA before 4 h was largely unchanged, but after 8 h Il6 mRNA remained elevated while control cells declined; IL-6 protein also increased, whereas Tnfa levels were similar. Tet3 silencing barely affected Il6.
- Tet2-deficient mice produced more IL-6 after systemic LPS, especially late, and showed worse lung tissue damage; in DSS colitis they had greater weight loss, higher IL-6, more inflammatory cell infiltration, and mucosal disruption. In Tet2-deficient BMDC, 22 genes were downregulated and 13 upregulated; 12 of the upregulated genes were TLR-induced, including Il6.
- IκBζ interacted with Tet2 and was required for Tet2 binding to the Il6 promoter at late LPS phase. IκBζ overexpression increased Il6 early but reduced it late, and Tet2 loss impaired this late repression.
- Tet2 associated with Hdac1/Hdac2 through its core-DSBH domain. Hdac2 binding at the Il6 promoter fell early and returned late; Hdac2 knockdown increased Il6 transcription and histone acetylation at 10 h, with Hdac1 compensation by 12 h. Catalytically mutant Tet2 still repressed Il6, and Tet2 loss reduced Hdac2 binding and late histone deacetylation.
Methods
- Mouse models included C57BL/6, Tet2fl/fl, Tet2-deficient, and Lyz2-Cre myeloid-specific Tet2-deficient mice; human monocytes came from healthy donors. Cells studied included BMDC, BMM, peritoneal macrophages, and splenic T, B, and NK cells, with LPS at 100 ng/ml; in vivo models were endotoxin shock and DSS colitis.
- Assays included RNA-seq, qPCR, ELISA, immunoblot, immunoprecipitation, co-IP with LC-MS/MS, ChIP and re-ChIP, luciferase reporters, siRNA knockdown, overexpression, and a GAL4-based recruitment assay.
- Statistics used unpaired Student’s t-tests with *P < 0.05 and P < 0.01; error bars were s.e.m. or s.d.; data were from triplicate technical or biological replicates and representative of three independent experiments.
Limitations
- The paper states that animal studies did not randomize by weight or sex and did not use blinding, and that sample size was not predetermined by a statistical method. It also states that HEK293T cells were not authenticated or tested for mycoplasma.
- Evident from the text: Hdac2 knockdown effects were transient because Hdac1 appeared to compensate by 12 h, complicating conclusions about Hdac2-specific repression.
- Evident from the text: many mechanistic experiments relied on overexpression or siRNA in HEK293T or primary cells, and the in vivo work used two inflammatory models; the authors note that additional Tet2-repressed mediators may exist in tissue-resident immune cells.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 16 Not checked · 86 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“MS-275 strongly inhibits Hdac1/2 over Hdac3 (ref. 19)”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
What the sources say
- Supportedcites [19] Inoue, S., Mai, A., Dyer, M. J. & Cohen, G. M. Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 66, 6785–6792 (2006) source
In the Results section 'Expression of HDACs in CLL cells and various cell lines', our copy reports that MS-275 (1-2.5 micromol/L) inhibited HDAC1 and HDAC2 activities by ~50-70% whereas 1 micromol/L did not inhibit HDAC3 (~20% only at 2.5 micromol/L), and explicitly frames the experiment as confirming that 'MS-275 was selectively inhibiting HDAC1 and HDAC2 rather than HDAC3'. The same section also states MS-275 preferentially inhibits HDAC1 (IC50 ~0.3 micromol/L) versus HDAC3 (IC50 ~8 micromol/L), though that IC50 comparison is itself credited to ref. 32; the paper's own immunoprecipitation/activity data carry the claim. Thus the paraphrase 'strongly inhibits Hdac1/2 over Hdac3' matches what this source attributes to MS-275. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“overexpressed Tet2 recruited more endogenous Hdac2 to the Il6 promoter”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Attenuated histone deacetylation in Tet2-deficient cells was also observed at late phase during LPS response”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“loss of Tet2 caused higher expression of IFN-γ in activated CD8+ T cells”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Loss of Tet2 barely affects TLR4 signalling pathways”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Extended Data
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
45 more claims
Create a free account to see all 103 claims and to verify the 15 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 28
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mice deficient in Tet2 developed more severe inflammation in several tissues upon challenge with bacterial endotoxin”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this effect on Il6 expression was independent of the catalytic function of Tet2”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“loss of TET2, an enzyme that catalyzes DNA demethylation, results in prolonged and high expression of proinflammatory cytokines, including IL-6 [180].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [180]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As CHIP-associated mutations are known to alter the development and function of myeloid cells”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results contrast with findings in peripheral macrophages after intraperitoneal injection in vivo (Zhang et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Zhang et al., 2015
Experimental — accuracy not yet measured
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Ito, S., D’Alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C., & Zhang, Y. (2010) · Nature · doi:10.1038/nature09303 · Cited by 2,373
TET enzymes, TDG and the dynamics of DNA demethylation
Kohli, R. M., & Zhang, Y. (2013) · Nature · doi:10.1038/nature12750 · Cited by 1,623
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563
Gene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Self-citationImpaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Ko, M., Huang, Y., Jankowska, A. M., Pape, U. J., Tahiliani, M., Bandukwala, H. S., An, J., Lamperti, E. D., Koh, K. P., Ganetzky, R., et al. (2010) · Nature · doi:10.1038/nature09586 · Cited by 1,213
Distinct Effects of T-bet in T H 1 Lineage Commitment and IFN-γ Production in CD4 and CD8 T Cells
Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P., & Glimcher, L. H. (2002) · Science · doi:10.1126/science.1065543 · Cited by 1,172
Cited by
Items 101–200 of 797
de Groot, A. E., & Pienta, K. J. (2018) · Oncotarget · doi:10.18632/oncotarget.24556 · Cited by 135
“Additionally, M1 polarization by LPS-stimulation of human and mouse macrophages upregulates expression of TET2 which acts as a co-repressor of Il6 transcription alongside HDAC2 [24].”
BackgroundInfluentialClonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity
Cook, E. K., Luo, M., & Rauh, M. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.011 · Cited by 121
Reprogramming the epigenome with vitamin C
Lee Chong, T., Ahearn, E. L., & Cimmino, L. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00128 · Cited by 120
“Patients with Werner Syndrome (WS), exhibit premature aging phenotypes such as gray hair, osteoporosis, diabetes and cancer due to loss-of-function mutations of the WRN gene, which is involved in DNA repair and telomere maintenance (Burtner and Kennedy, 2010; Zhang et al., 2015).”
BackgroundPotus, F., Pauciulo, M. W., Cook, E. K., Zhu, N., Hsieh, A., Welch, C. L., Shen, Y., Tian, L., Lima, P., Mewburn, J. D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044320 · Cited by 133
The Emerging Role of Epigenetics in Inflammation and Immunometabolism
Raghuraman, S., Donkin, I., Versteyhe, S., Barrès, R., & Simar, D. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.06.008 · Cited by 124
Jan, M., Ebert, B. L., & Jaiswal, S. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.10.002 · Cited by 116
“In this model, a single unifying core gene expression pattern would not be predicted.”
TET Enzymes in the Immune System: From DNA Demethylation to Immunotherapy, Inflammation, and Cancer
López-Moyado, I. F., Ko, M., Hogan, P. G., & Rao, A. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-080223-044610 · Cited by 128
Das Gupta, K., Shakespear, M. R., Iyer, A., Fairlie, D. P., & Sweet, M. J. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2015.46 · Cited by 115
Function determinants of TET proteins: the arrangements of sequence motifs with specific codes
Liu, D., Li, G., & Zuo, Y. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby053 · Cited by 117
How I treat chronic myelomonocytic leukemia
Solary, É., & Itzykson, R. (2017) · Blood · doi:10.1182/blood-2017-04-736421 · Cited by 127
Vlasschaert, C., McNaughton, A. J. M., Chong, M., Cook, E. K., Hopman, W., Kestenbaum, B., Robinson-Cohen, C., Garland, J., Moran, S. M., Paré, G., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021060774 · Cited by 110
Ma, S., Wan, X., Deng, Z., Shi, L., Hao, C., Zhou, Z., Zhou, C., Fang, Y., Liu, J., Yang, J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161149 · Cited by 115
“In this regard, pDC depletion or dysfunction has been linked to a variety of human chronic infections, especially the infections caused by HIV (Chehimi et al., 2002; Li et al., 2014; Zhang et al., 2015b), hepatitis B virus (Duan et al., 2004), and hepatitis C virus (Decalf et al., 2007).”
BackgroundSelf-citationThe Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer
Long, M. D., Smiraglia, D. J., & Campbell, M. J. (2017) · Biomolecules · doi:10.3390/biom7010015 · Cited by 121
“There is some evidence for TET2 and TET3 to target specific gene regulation programs, for example the active repression of interleukin 6 (IL6) during inflammation through active recruitment of histone deacetylases (HDAC) independently of modification of 5mC [46].”
BackgroundSNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response
Chen, L., Lin, H.-P., Zhou, W.-J., He, C.-X., Zhang, Z.-Y., Cheng, Z., Song, J., Liu, P., Chen, X.-Y., Xia, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.028 · Cited by 115
“, 2011), immune response (Ichiyama et al., 2015; Yang et al., 2015; Zhang et al., 2015), cardiac protection (Fuster et al.”
CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors
Reed, S. C., Croessmann, S., & Park, B. H. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2598 · Cited by 118
Ito, K., Lee, J., Chrysanthou, S., Zhao, Y., Josephs, K., Sato, H., Teruya-Feldstein, J., Zheng, D., Dawlaty, M. M., & Ito, K. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.094 · Cited by 114
“Tet2 has also been implicated in formation of chromatin regulatory complexes with O-linked N-acetylglucosamine transferase (OGT) and histone deacetylases (HDACs) to regulate transcription and histone modifications (Chen et al., 2013; Williams et al., 2011; Wu et al., 2011; Zhang et al., 2015).”
BackgroundClonal hematopoiesis, somatic mosaicism, and age-associated disease
Evans, M. A., & Walsh, K. X. (2022) · Physiological Reviews · doi:10.1152/physrev.00004.2022 · Cited by 116
TET2 Regulates the Neuroinflammatory Response in Microglia
Carrillo-Jimenez, A., Deniz, Ö., Niklison-Chirou, M. V., Ruiz, R., Bezerra-Salomão, K., Stratoulias, V., Amouroux, R., Yip, P. K., Vilalta, A., Cheray, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.013 · Cited by 104
Kapellos, T. S., & Iqbal, A. J. (2016) · Mediators of Inflammation · doi:10.1155/2016/6591703 · Cited by 106
“showed that TET2 actively represses IL-6 during the resolution phase of inflammation [52].”
BackgroundGroarke, E. M., & Young, N. S. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.03.001 · Cited by 117
RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis
Zou, Z., Dou, X., Li, Y., Zhang, Z., Wang, J., Gao, B., Xiao, Y., Wang, Y., Zhao, L., Sun, C., et al. (2024) · Nature · doi:10.1038/s41586-024-07969-x · Cited by 103
“By contrast, tethering of HxD did not alter DNA or RNA methylation, demonstrating that this effect is dependent on its oxidation activities but not the protein scaffolding effect 31 .”
Role of Methylation in Pro- and Anti-Cancer Immunity
Mehdi, A., & Rabbani, S. A. (2021) · Cancers · doi:10.3390/cancers13030545 · Cited by 111
“Furthermore, Tet2-deficient mice are more susceptible to septic shock and colitis induced by endotoxin and dextran sulfate sodium (DSS), respectively, both due to elevated IL-6 expression [69].”
BackgroundMembrane Fusion‐Mediated Loading of Therapeutic siRNA into Exosome for Tissue‐Specific Application
Xie, M., Wu, Y., Zhang, Y., Lu, R., Zhai, Z., Huang, Y., Wang, F., Xin, C., Rong, G., Zhao, C., et al. (2024) · Advanced Materials · doi:10.1002/adma.202403935 · Cited by 111
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
Hemmati, S., Haque, T., & Gritsman, K. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00265 · Cited by 101
“They showed that Tet2 mediates this repression by recruiting histone deacetylase 2 (HDAC2) to prevent constant transcriptional activation of IL-6 in response to inflammation (115).”
BackgroundClonal hematopoiesis in cardiovascular disease and therapeutic implications
Tall, A. R., & Fuster, J. J. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00015-3 · Cited by 105
Lv, L., Wang, Q., Xu, Y., Tsao, L.-C., Nakagawa, T., Guo, H., Su, L., & Xiong, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.05.007 · Cited by 100
“It was recently reported that during inflammation resolution phase Tet2 was recruited by IkBz to IL-6 promoter, and Tet2 in turn recruits HDAC1/2 to actively repress the transcription of IL-6 (Zhang et al., 2015), a pleiotropic cytokine that has pro- and anti-inflammatory properties and the increased levels of which h…”
BackgroundResultCHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice
DeZern, A. E., Malcovati, L., & Ebert, B. L. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_239083 · Cited by 98
Immunometabolism of Phagocytes During Mycobacterium tuberculosis Infection
Kumar, R., Singh, P., Kolloli, A., Shi, L., Bushkin, Y., Tyagi, S., & Subbian, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00105 · Cited by 124
“Also, HDAC3 regulates inflammatory genes in macrophages, while HDAC2 resolves inflammation by suppressing IL-6 (Chen et al., 2014; Zhang et al., 2015).”
BackgroundMade to order: emergency myelopoiesis and demand-adapted innate immune cell production
Swann, J. W., Olson, O. C., & Passegue, E. A. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-00998-7 · Cited by 116
“Similarly, TET2-deficient macrophages have increased expression of the NLRP3 inflammasome and IL-1β in mouse models of cardiovascular disease 183 and are unable to terminate inflammatory IL-6 production in response to lipopolysaccharide 184 .”
Afridi, R., Kim, J.-H., Rahman, M. H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00020 · Cited by 98
Ironing Out the Details: How Iron Orchestrates Macrophage Polarization
Xia, Y., Li, Y., Wu, X., Zhang, Q., Chen, S., Ma, X., & Yu, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669566 · Cited by 105
“Moreover, it has been shown that teneleven translocation family proteins (Tets) [which are iron (II) Frontiers in Immunology | www.frontiersin.org 7 and a-ketoglutarate (a-KG)-dependent demethylases (102– 104)] promote (by Tet1) (105) or restrain (through Tet2) (106, 107) pro-inflammatory responses in macrophages thro…”
BackgroundSelf-citationEpigenomic analysis of Parkinson’s disease neurons identifies Tet2 loss as neuroprotective
Marshall, L. L., Killinger, B. A., Ensink, E., Li, P., Li, K. X., Cui, W., Lubben, N., Weiland, M. J., Wang, X., Gordevičius, J., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0690-y · Cited by 105
The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
Yeaton, A., Cayanan, G., Loghavi, S., Dolgalev, I., Leddin, E. M., Loo, C. E., Torabifard, H., Nicolet, D., Wang, J., Corrigan, K., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1146 · Cited by 94
Montagner, S., Leoni, C., Emming, S., Della Chiara, G., Balestrieri, C., Barozzi, I., Piccolo, V., Togher, S., Ko, M., Rao, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.044 · Cited by 93
“…complexes mapped the main region mediating proteinprotein interactions to the carboxy-terminal catalytic domain of TET2 (Chen et al., 2013; Zhang et al., 2015); consistently, we found that this same region was able to rescue proliferation of Tet2-deleted mast cells, independently of its…”
BackgroundInfluentialLio, C. J., Shukla, V., Samaniego‐Castruita, D., González‐Avalos, E., Chakraborty, A., Yue, X., Schatz, D. G., Ay, F., & Rao, A. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau7523 · Cited by 107
Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity
Tanaka, S., Ise, W., Inoue, T., Ito, A., Ono, C., Shima, Y., Sakakibara, S., Nakayama, M., Fujii, K., Miura, I., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0700-y · Cited by 103
Immunity drives TET1 regulation in cancer through NF-κB
Collignon, É., Canale, A., Wardi, C. A., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W. J., Wilson, A. J., et al. (2018) · Science Advances · doi:10.1126/sciadv.aap7309 · Cited by 99
Lorente‐Sorolla, C., García-Gómez, A., Català‐Moll, F., Toledano, V., Ciudad, L., Ortiz, J. A., Maroun‐Eid, C., Martín‐Quirós, A., Martínez‐Gallo, M., Ruiz-Sanmartín, A., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0674-2 · Cited by 105
Trained Immunity: Long-Term Adaptation in Innate Immune Responses
Tercan, H., Riksen, N. P., Joosten, L. A. B., Netea, M. G., & Bekkering, S. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314212 · Cited by 97
Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis
Liu, W., Yalcinkaya, M., Maestre, I. F., Olszewska, M., Ampomah, P. B., Heimlich, J. B., Wang, R., Vela, P. S., Xiao, T., Bick, A. G., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00281-3 · Cited by 93
Self-citationImpact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
Kaasinen, E., Kuismin, O., Rajamäki, K., Ristolainen, H., Aavikko, M., Kondelin, J., Saarinen, S., Berta, D. G., Katainen, R., Hirvonen, E. A. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09198-7 · Cited by 92
Demethylase Kdm6a epigenetically promotes IL-6 and IFN-β production in macrophages
Li, X., Zhang, Q., Shi, Q., Liu, Y., Zhao, K., Shen, Q., Shi, Y., Liu, X., Wang, C., Li, N., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.02.007 · Cited by 96
“expression, we transfected HEK293T cells with vectors encoding wild-type or mutated Kdm6a, and then detected the Il6 gene promoter activation through luciferase reporter assay as previously reported [23].”
BackgroundMethodSelf-citationTet2 at the interface between cancer and immunity
Jiang, S. (2020) · Communications Biology · doi:10.1038/s42003-020-01391-5 · Cited by 100
Busque, L., Sun, M., Buscarlet, M., Ayachi, S., Feroz Zada, Y., Provost, S., Bourgoin, V., Mollica, L., Meisel, M., Hinterleitner, R., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000770 · Cited by 87
“Such a model has been demonstrated for chronic myelogenous leukemia in which stem cells have increased IL-1 receptor activity,36 and increased proliferation and survival in a proinflammatory environment.37 Furthermore, in a recent meta-analysis of inflammatory cytokine profile of 697 individuals with myelodysplastic s…”
BackgroundInfluentialEpigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment
García-Gómez, A., Rodríguez‐Ubreva, J., & Ballestar, E. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.02.013 · Cited by 91
KAT8 selectively inhibits antiviral immunity by acetylating IRF3
Huai, W., Liu, X., Wang, C., Zhang, Y., Chen, X., Chen, X., Xu, S., Thomas, T., Li, N., & Cao, X. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181773 · Cited by 87
Self-citationDainichi, T., Matsumoto, R., Mostafa, A., & Kabashima, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01107 · Cited by 95
Peng, J., Yang, Q., Li, A., Li, R., Zuo, W., Liu, L., Ren, Z., Zheng, X., Tang, X., Li, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13121 · Cited by 87
The Role of Host Cell DNA Methylation in the Immune Response to Bacterial Infection
Qin, W., Scicluna, B. P., & van der Poll, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696280 · Cited by 94
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 99
Epigenetic reprogramming of immune cells in injury, repair, and resolution
Placek, K., Schultze, J. L., & Aschenbrenner, A. C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124619 · Cited by 91
“Resolution of arthritis is promoted by HDAC2’s interaction with Tet2, leading to deacetylation and thus repression of the Il6 locus (82).”
BackgroundMarkopoulos, G. S., Roupakia, E., Marcu, K. B., & Kolettas, E. (2019) · Cells · doi:10.3390/cells8101143 · Cited by 81
Inflammatory bone marrow microenvironment
Leimkühler, N. B., & Schneider, R. K. (2019) · Hematology · doi:10.1182/hematology.2019000045 · Cited by 82
“Tet2knockout murine and TET2-mutant human HSPCs have a clonal advantage caused by resistance to apoptosis in an in vitro environment that contains the proinflammatory cytokine TNFa.85 TET2-deficient macrophages are hyperinflammatory, and this may exacerbate processes by propagating an inflammatory environment.”
BackgroundTargeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
Zhang, S., Meng, Y., Zhou, L., Qiu, L., Wang, H., Su, D., Zhang, B., Chan, K. M., & Han, J. (2022) · MedComm · doi:10.1002/mco2.173 · Cited by 93
Germline risk of clonal haematopoiesis
Silver, A. J., Bick, A. G., & Savona, M. R. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00356-6 · Cited by 82
DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism
Shen, J., Wang, C., Li, D., Xu, T., Myers, J. R., Ashton, J. M., Wang, T., Zuscik, M. J., McAlinden, A., & O’Keefe, R. J. (2017) · JCI Insight · doi:10.1172/jci.insight.93612 · Cited by 85
“proteins can inhibit inflammatory signals in other systems (40, 41).”
BackgroundSelf-citationSun, D., Chang, Q., & Lu, F. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241265202 · Cited by 83
“78 Zhang et al. 79 demonstrated that the recruitment of HDAC2 selectively inhibits IL-6 transcription, thereby promoting inflammation resolution, while HDAC2 loss induces up-regulation of various inflammatory mediators during late lipopolysaccharide reaction.”
BackgroundZhao, D., Zhang, Q., Liu, Y., Li, X., Zhao, K., Ding, Y., Li, Z., Shen, Q., Wang, C., Li, N., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.035 · Cited by 83
Self-citationThe potential role of vitamin C in empowering cancer immunotherapy
Bedhiafi, T., Inchakalody, V. P., Fernandes, Q., Mestiri, S., Billa, N., Shahab Uddin, M. S., Merhi, M., & Dermime, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112553 · Cited by 82
Mechanically Robust Hydrogels Facilitating Bone Regeneration through Epigenetic Modulation
Yu, T., Zhang, L., Dou, X., Bai, R., Wang, H., Deng, J., Zhang, Y., Sun, Q., Li, Q., Wang, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202203734 · Cited by 79
Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil
Busque, L., Buscarlet, M., Mollica, L., & Levine, R. L. (2018) · Stem Cells · doi:10.1002/stem.2845 · Cited by 78
Self-citationFerrone, C. K., Blydt-Hansen, M., & Rauh, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020626 · Cited by 74
“During the resolution of inflammation, TET2 normally recruits histone deacetylase 2 (HDAC2) to deacetylate IL6, thereby repressing its transcription and IL-6 levels [66].”
BackgroundLoss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils
Huerga Encabo, H., Aramburu, I. V., Garcia-Albornoz, M., Piganeau, M., Wood, H., Song, A., Ferrelli, A., Sharma, A., Minutti, C. M., Domart, M.-C., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.05.004 · Cited by 81
Portraits of TET-mediated DNA hydroxymethylation in cancer
Jeschke, J., Collignon, É., & Fuks, F. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.01.004 · Cited by 80
Environmental influences on clonal hematopoiesis
King, K. Y., Huang, Y., Nakada, D., & Goodell, M. A. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.005 · Cited by 73
“, 2016), inflammation (Cai et al., 2018; Shen et al., 2018; Zhang et al., 2015) and changes in the microbiota (Meisel et al.”
BackgroundRBP–RNA interactions in the control of autoimmunity and autoinflammation
Liu, J., & Cao, X. (2023) · Cell Research · doi:10.1038/s41422-022-00752-5 · Cited by 83
“TET2 also recruits histone deacetylases HDAC1/2 to repress transcription of Il6 and Il1β via histone deacetylation in innate myeloid cells including DCs and macrophages, thus mediating inflammation resolution.(121) The identification of RNA-binding capacity and potential RNA-binding site of TET2 suggests TET2 as a pot…”
BackgroundSelf-citationZhao, K., Zhang, Q., Li, X., Zhao, D., Liu, Y., Shen, Q., Yang, M., Wang, C., Li, N., & Cao, X. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501224 · Cited by 76
“Mouse peritoneal macrophages were transfected using the mouse Macrophage Nucleofector Transfection kit (Amaxa), according to the manufacturer’s manual, as described previously (28).”
MethodSelf-citationTet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis
Pandey, S. P., Bender, M. J., McPherson, A. C., Phelps, C. M., Sanchez, L. M., Rana, M., Hedden, L., Sangani, K. A., Chen, L., Shapira, J. H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.05.006 · Cited by 72
Air pollution, epigenetics, and asthma
Ji, H., Myers, J. M. B., Brandt, E. B., Brokamp, C., Ryan, P., & Hershey, G. K. K. (2016) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-016-0159-4 · Cited by 77
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review
Arguelles, O. C., Jaiswal, S., Shlush, L. I., Moslehi, J. J., Schimmer, A. D., Barac, A., & Thavendiranathan, P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0302 · Cited by 79
Low shear stress induced vascular endothelial cell pyroptosis by TET2/SDHB/ROS pathway
Chen, J., Zhang, J., Wu, J., Zhang, S., Liang, Y., Zhou, B., Wu, P., & Wei, D. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.11.017 · Cited by 75
TET Methylcytosine Oxidases in T Cell and B Cell Development and Function
Tsagaratou, A., Lio, C. J., Yue, X., & Rao, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00220 · Cited by 83
“Tet2-deficient macrophages and dendritic cells produce more IL-6 in response to stimulation, rendering Tet2-deficient mice more susceptible than WT mice to endotoxin-induced shock and DSS-induced colitis (51).”
BackgroundInfluentialRodríguez‐Ubreva, J., de la Calle‐Fabregat, C., Li, T., Ciudad, L., Ballestar, M. L., Català‐Moll, F., Morante-Palacios, O., García-Gómez, A., Celis, R., Humby, F., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215355 · Cited by 73
DNA methylation and hydroxymethylation in hematologic differentiation and transformation
Ko, M., An, J., & Rao, A. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.10.009 · Cited by 70
Desplats, P., Gutierrez, A. M., Antonelli, M. C., & Frasch, M. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.013 · Cited by 86
Li, B., Zang, G., Zhong, W. H., Chen, R., Zhang, Y., Yang, P., & Yan, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109593 · Cited by 72
Chavakis, T., Wielockx, B., & Hajishengallis, G. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-052521-013627 · Cited by 76
Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer
Huilgol, D., Venkataramani, P., Nandi, S., & Bhattacharjee, S. (2019) · Genes · doi:10.3390/genes10100794 · Cited by 83
“Mutations in these enzymes have been implicated in myeloid leukemia [65] and late onset B-cell lymphoma [66,67].”
BackgroundZeng, Z., Li, T., Liu, X., Ma, Y., Luo, L., Wang, Z., Zhao, Z., Li, H., He, X., Zeng, H., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102916 · Cited by 71
“Notably, specific deletion of TET2 in myeloid cells exacerbated inflammation and destruction of lung tissue caused by LPS [23].”
BackgroundInnate recognition of microbial-derived signals in immunity and inflammation
Zhang, Y., & Liang, C. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0325-6 · Cited by 80
“Zhang et al. have recently reported that DNA modifier Tet2 is required to resolve inflammation by recruiting Hdac2 to selectively repress transcription of IL-6 via histone deacetylation (Zhang et al., 2015).”
BackgroundAndersen, M., Sajid, Z., Pedersen, R. K., Gudmand‐Hoeyer, J., Ellervik, C., Skov, V., Kjær, L., Pallisgaard, N., Kruse, T. A., Thomassen, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183620 · Cited by 72
Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
Yura, Y., Sano, S., & Walsh, K. X. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.08.006 · Cited by 76
“Consistent with a previous report (69), it was found that Tet2 regulates IL-1b expression through its ability to modulate histone acetylation rather than DNA methylation (66).”
BackgroundHajishengallis, G., Li, X., Divaris, K., & Chavakis, T. (2022) · Periodontology 2000 · doi:10.1111/prd.12421 · Cited by 74
Self-citationChrysanthou, S., Tang, Q., Lee, J., Taylor, S. J., Zhao, Y., Steidl, U., Zheng, D., & Dawlaty, M. M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac089 · Cited by 64
Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye
Wen, X., Hu, X., Li, M., Ge, X., Deng, Y., Bible, P. W., & Wei, L. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.01.001 · Cited by 72
Epigenetics, DNA Organization, and Inflammatory Bowel Disease
Ray, G., & Longworth, M. S. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy330 · Cited by 70
Nakatsukasa, H., Oda, M., Yin, J., Chikuma, S., Ito, M., Iizuka-Koga, M., Someya, K., Kitagawa, Y., Ohkura, N., Sakaguchi, S., et al. (2019) · International Immunology · doi:10.1093/intimm/dxz008 · Cited by 66
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63
SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2
Singh, A. K., Khare, P. S., Obaid, A., Conlon, K. P., Basrur, V., DePinho, R. A., & Venuprasad, K. (2018) · Nature Communications · doi:10.1038/s41467-018-06924-5 · Cited by 67
Dual mechanisms of posttranscriptional regulation of Tet2 by Let-7 microRNA in macrophages
Jiang, S., Yan, W., Wang, S. E., & Baltimore, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811040116 · Cited by 67
“Tet2-deficient mice are highly susceptible to dextran sulfate-induced colitis, with a more severe inflammatory phenotype and increased IL-6 production compared with WT control mice (6).”
BackgroundGondek, L. P., & DeZern, A. E. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30211-x · Cited by 63
TET1 is a beige adipocyte-selective epigenetic suppressor of thermogenesis
Villivalam, S. D., You, D., Kim, J., Lim, H., Han, X., Zushin, P.-J. H., Oguri, Y., Amin, P., & Kang, S. (2020) · Nature Communications · doi:10.1038/s41467-020-18054-y · Cited by 69
Interleukin-1 (IL-1) and the inflammasome in cancer
Prêtre, V., Papadopoulos, D., Regard, J. B., Pelletier, M. R., & Woo, J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155850 · Cited by 70
Transcriptional determination and functional specificity of myeloid cells: making sense of diversity
Monticelli, S., & Natoli, G. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.51 · Cited by 72
Guan, Y., Tiwari, A. D., Phillips, J. G., Hasipek, M., Grabowski, D., Pagliuca, S., Gopal, P., Kerr, C. M., Ademà, V., Radivoyevitch, T., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0173 · Cited by 64
Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes
Kao, S.-H., Wu, K., & Lee, W. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020024 · Cited by 68
“TET2 also recruits Hdac2 to repress IL-6 gene expression independent of its DNA demethylating activity [88].”
Falini, B., & Martelli, M. P. (2023) · American Journal of Hematology · doi:10.1002/ajh.26812 · Cited by 64
“An increased risk of progression has been associated with >1 driver mutation, a VAF >10%, and the acquisition of additional mutations.16,17 TP53 mutations occur rarely in patients with CCUS, but an increase in VAF is associated with faster progression to MDS.18 Thus, CCUS patients, even in the absence of dysplasia, sh…”
BackgroundInfluentialEpigenetic Changes in Chronic Inflammatory Diseases
Fogel, O., Miceli‐Richard, C., & Tost, J. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.09.003 · Cited by 73
Epigenetics in myelodysplastic syndromes
Heuser, M., Yun, H., & Thol, F. R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.009 · Cited by 66
The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3
Wang, C., Wang, Q., Xu, X., Xie, B., Zhao, Y. B., Li, N., & Cao, X. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170856 · Cited by 61
Self-citation
Metadata
- Authors
- Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., Su, X., Liu, J., Ge, W., Levine, R. L., Li, N., & Cao, X.
- Affiliations
- Second Military Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Cao, Xuetao
- ORCID
- Venue
- Nature
- Published
- 2015-08-19
- Volume
- 525
- Issue
- 7569
- Pages
- 389-393
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4697747
- OpenAlex
- W1171241794
- Cited by
- 807
- References
- 30
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 83 · 2023: 89 · 2022: 93 · 2021: 82 · 2020: 79 · 2019: 85 · 2018: 62 · 2017: 50 · 2016: 43 · 2015: 7
- FWCI
- 23.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA173636, P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TET2, HDAC2, interleukin-6, inflammation resolution, histone deacetylation, transcriptional repression, 5-hydroxymethylcytosine, IκB, lipopolysaccharide, dendritic cells, macrophages, endotoxic shock, DSS-induced colitis
- MeSH terms
- Interleukin-6 Inhibitors, Acetylation, Animals, Chromatin, Colitis, Dendritic Cells, DNA-Binding Proteins, Female, Histones, Humans, Inflammation, Macrophages, Male, Mice, Inbred C57BL, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription, Genetic, Down-Regulation, Interleukin-6, DNA Methylation, I-kappa B Proteins, Epigenesis, Genetic, Dioxygenases, Mice, Histone Deacetylase 2, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.